| 品牌 | 货号 | 产品名称 | 规格 | 货期 | 单价 | 操作 |
| Biomatik | RPC28047 | Recombinant Human Tumor necrosis factor receptor superfamily member 14 (TNFRSF14), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28048 | Recombinant Human Hepatocyte growth factor receptor (MET), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28049 | Recombinant Human CD40 ligand (CD40LG), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28050 | Recombinant Macaca fascicularis Angiotensin-converting enzyme (ACE2), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28051 | Recombinant Human B- and T-lymphocyte attenuator (BTLA), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28052 | Recombinant Human Retinol-binding protein 4 (RBP4), Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28053 | Recombinant Human Secreted and transmembrane protein 1 (SECTM1), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28054 | Recombinant Human Tumor necrosis factor ligand superfamily member 14 (TNFSF14), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28056 | Recombinant Human Neural cell adhesion molecule L1 (L1CAM), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28057 | Recombinant Human Basigin (BSG), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28058 | Recombinant Human T-cell antigen CD7 (CD7), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28059 | Recombinant Paguma larvata Angiotensin-converting enzyme 2 (ACE2), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28060 | Recombinant Human Tumor necrosis factor receptor superfamily member 18 (TNFRSF18), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28061 | Recombinant Human Tumor necrosis factor ligand superfamily member 18 (TNFSF18), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |
| Biomatik | RPC28062 | Recombinant Human T-cell immunoreceptor with Ig and ITIM domains (TIGIT), partial, Active Protein | | 4-5周 | ¥0.00 | 详情 |